Voltammetric Determination of Manganese on Organo – Modified Electrodes

The researches on the choice of aryldiazonium tosylate salts as a modifier to create an organo-modified electrode were carried out. It is shown that the best organic modifier for surface modification of a mercury-graphite electrode is aryldiazonium tosylate without a substituent. A method for producing an organo-modified electrode and the procedure for measuring the analytical signal of manganese by voltammetry was developed. The method is simple to implement and allows avoiding the use of metal mercury for forming the electrode, and making measurements without aerating of electrolyte by inert gases (nitrogen, argon) with an error (Sr) of not more than 10%

Voltammetric Determination of Manganese on Organo – Modified Electrodes

The researches on the choice of aryldiazonium tosylate salts as a modifier to create an organo-modified electrode were carried out. It is shown that the best organic modifier for surface modification of a mercury-graphite electrode is aryldiazonium tosylate without a substituent. A method for producing an organo-modified electrode and the procedure for measuring the analytical signal of manganese by voltammetry was developed. The method is simple to implement and allows avoiding the use of metal mercury for forming the electrode, and making measurements without aerating of electrolyte by inert gases (nitrogen, argon) with an error (Sr) of not more than 10%

Development new radiopharmaceutical based on 5-thio-d- glucose labeled technetium-99m

The article considers the obtaining and possibility of using 5-thio-D-glucose labeled technetium-99m for the diagnosis of malignant tumors by single photon emission computed tomography. The analysis of the level of international developments of radiopharmaceuticals based on derivatives of glucose has been carried out. Also the article provides information on of using experimental batches of lyophilisate on the basis of 5-thio-D-glucose for preliminary biomedical testing on the mice

Unexpected “Lazarus response” to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer

Early clinical trials aimed to halt cancer progression by inhibiting the growth of new blood vessels in tumors through single-agent targeted therapy with bevacizumab. These trials largely proved unsuccessful. However, bevacizumab turned out to be efficient when administered in combination with other anticancer drugs. The efficacy of this approach is explained by the ability of bevacizumab to eliminate immature blood vessels thus normalizing intratumoral blood flow and improving the delivery of cytotoxic or targeted agents. This report describes four cases of heavily pretreated patients with metastatic HER2-positive breast cancer, who had no meaningful treatment options left, and who received single-agent bevacizumab as an empirical last-resort therapy. Three of these patients had severe complaints, and they demonstrated striking symptomatic relief within the first day of this treatment. In addition to the observed “Lazarus response”, which was likely attributed to the bevacizumab-driven resolution of edema, some evidence of a direct antitumor effect was observed. These data may call for the reconsideration of bevacizumab monotherapy in patients with HER2-associated breast cancer, and perhaps in some other categories of cancer patients

Yb,Er:glass Microlaser at 1.5 μm for optical fibre sensing: Development, characterization and noise reduction

A fiber-pumped single-frequency microchip erbium laser was developed and characterized with the aim of using it in coherent Optical Time Domain Reflectometry (OTDR) measurements and sensing. The laser is pumped by a fiber-coupled 976 nm laser diode and provides 8 mW TEM00 single-frequency output power at 1.54 μm wavelength, suitable for efficient coupling to optical fibers. The amplitude and phase noise of this 200 THz oscillator were experimentally investigated and a Relative Intensity Noise (RIN) control loop was developed providing 27 dB RIN peak reduction at the relaxation oscillation frequency of 800 kHz

Factors affecting eluation characteristics of sorption generators of technetium-99m

The influence of the adsorbed mass of molybdenum on the width of eluation profiles of generators and the patterns of molybdenum distribution in the amount of chromatographic columns by scanning them on the germanium-gallium detector using collimating device are studied. The boundary conditions under which the maximum value of {99m}Tc yield from generators Y[e]=1 are defined. After scanning the columns, it was found out that the degree of filling the columns with molybdenum Q and the value of its maximum adsorption depend naturally on the total weight of the adsorbed mass. In order to achieve the condition Y[e]=1 the value of Q should be at least 85%

The study of interaction of modified fatty acid with {99m}Tc in alcoholic media

The paper presents the results of laboratory research aimed at the development of methods of synthesis of new radiodiagnostic agents based on modified fatty acid labelled with technetium-99m intended for scintigraphic evaluation of myocardial metabolism. In particular, the interaction of substance with {99m}Tc in alcoholic media and the use of ethanol as solvent in the synthesis of the radiopharmaceutical were studied

99mTc-labeled monosaccharide kits: development methods and quality control

The paper presents the procedure for planning an experiment to create standard sets of reagents for a technetium-99m generator based on glucose derivatives. All stages are presented from researching the required quantities of a substance, a reducing agent, a stabilizer and auxiliary components to developing lyophilized kits and conducting quality control. The radiochemical purity of radiopharmaceuticals prepared on the basis of the developed kits ranged from 90.0 to 99.0%. We also showed the functional suitability of the developed preparations on C57B1/6j mice with an implanted malignant tumor - Lewis lung carcinoma